Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493152-17-013369
Filing Date
2017-11-15
Accepted
2017-11-15 17:26:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 form13d-a6.htm SC 13D/A 56651
  Complete submission text file 0001493152-17-013369.txt   58230
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 5105213390
BIOTIME INC (Filed by) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address 6300 DUMBARTON CIRCLE FREMONT CA 94555 510-456-3805
Asterias Biotherapeutics, Inc. (Subject) CIK: 0001572552 (see all company filings)

EIN.: 461047971 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87639 | Film No.: 171206065
SIC: 2836 Biological Products, (No Diagnostic Substances)